Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the retrospective multicenter analysis for femoropopliteal stenting (REAL-FP)

Catheterization and Cardiovascular Interventions

Volumn 90, Issue 5, 2017, Pages 790-797

  Kamioka, Norihiko ^a   Soga, Yoshimitsu ^a   Kuramitsu, Shoichi ^a   Iida, Osamu ^b   Hirano, Keisuke ^c   Suzuki, Kenji ^d   Kawasaki, Daizo ^e   Yamaoka, Terutoshi ^f   Suematsu, Nobuhiro ^g   Shintani, Yoshiaki ^h   Miyashita, Yusuke ⁱ   Takahashi, Hiroki ^j   Tsuchiya, Taketsugu ^k   Shinozaki, Norihiko ^l   Okazaki, Shinya ^m   Ando, Kenji ^a  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b KANSAI ROSAI HOSPITAL   (Japan)

^c SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^d SENDAI KOUSEI HOSPITAL   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f MATSUYAMA RED CROSS HOSPITAL   (Japan)

^g FUKUOKA RED CROSS HOSPITAL   (Japan)

^h Shin Koga Hospital   (Japan)

ⁱ SHINSHU UNIVERSITY   (Japan)

^j YAMAGATA UNIVERSITY   (Japan)

^k KANAZAWA MEDICAL UNIVERSITY   (Japan)

^l TOKAI UNIVERSITY HOSPITAL   (Japan)

^m JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

more..

Author keywords

Balloon angioplasty; Endovascular therapy; Femoropopliteal disease; Small vessel diameter; Stent implantation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; PROSTACYCLIN DERIVATIVE; SARPOGRELATE; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN; ALLOY; NITINOL;

ADVERSE OUTCOME; AGED; ARTERY DIAMETER; ARTERY DISEASE; ARTERY LENGTH; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL OUTCOME; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FEMORAL ARTERY; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NITINOL STENT IMPLANTATION; OBSERVATIONAL STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; RETROSPECTIVE STUDY; VASCULAR PATENCY; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; JAPAN; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROPORTIONAL HAZARDS MODEL; PROSTHESIS DESIGN; RISK FACTOR; STENT; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY, BALLOON; DISEASE-FREE SURVIVAL; FEMALE; FEMORAL ARTERY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 85025065905     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.27192     Document Type: Article

References (32)

1. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, Minar E. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516-521.
2. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-2749.
3. Soga Y, Iida O, Hirano K, Yokoi H, Nanto S, Nobuyoshi M. Midterm clinical outcome and predictors of vessel patency after femo-ropopliteal stenting with self-expandable nitinol stent. J Vasc Surg 2010;52:608-615.
4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45(suppl S):S5-S67.
5. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-1888.
6. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR, RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-276.
7. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Kop-pensteiner R, Minar E, Schillinger M. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 2009;74:1090-1095.
8. Kasapis C, Henke PK, Chetcuti SJ, Koenig GC, Rectenwald JE, Krish-namurthy VN, Grossman PM, Gurm HS. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2009;30:44-55.
9. Soga Y, Takahara M, Iida O, Suzuki K, Hirano K, Kawasaki D, Shin-tani Y, Yamaoka T, Ando K. Relationship between primary patency and lesion length following bare nitinol stent placement for femoropopliteal disease. J Endovasc Ther 2015;22:862-867.
10. European Stroke Organisation Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T, ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-2906.
11. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 1994;90:1239-1251.
12. Doucet S, Schalij MJ, Vrolix MC, Hilton D, Chenu P, de Bruyne B, Udayachalerm W, Seth A, Bilodeau L, Reiber JH, Harel F, Lesperance J, Stent In Small Arteries(SISA) Trial Investigators. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001;104:2029-2033.
13. Chalmers N, Walker PT, Belli AM, Thorpe AP, Sidhu PS, Robinson G, van Ransbeeck M, Fearn SA. Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: The SUPER study. Cardiovasc Intervent Radiol 2013;36:353-361.
14. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 1992;18:433-440.
15. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, Yokoi H, Nanto S, Nobuyoshi M. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012;59:16-23.
16. Rogers C, Tseng DY, Squire JC, Edelman ER. Balloon-artery interac-tions during stent placement: A finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury. Circ Res 1999;84:378-383.
17. Soga Y, Yokoi H, Urakawa T, Iwabuchi M, Nobuyoshi M. Clinical impact of self-expandable stent diameter after femoropopliteal stenting. Cardiovasc Interv Ther 2011;26:38-44.
18. Iida O, Soga Y, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M, Mura-matsu T, Inoue N, Nanto S, Uematsu M. Long-term outcomes and risk stratification of patency following nitinol stenting in the femo-ropopliteal segment: retrospective multicenter analysis. J Endovasc Ther 2011;18:753-761.
19. Acin F, de Haro J, Bleda S, Varela C, Esparza L. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther 2012;19:585-595.
20. Armstrong EJ, Saeed H, Alvandi B, Singh S, Singh GD, Yeo KK, Anderson D, Westin GG, Dawson DL, Pevec WC, Laird JR. Nitinol self-expanding stents vs. balloon angioplasty for very long femoro-popliteal lesions. J Endovasc Ther 2014;21:34-43.
21. Krankenberg H, Schluter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation 2007;116:285-292.
22. Miki K, Fujii K, Fukunaga M, Kawasaki D, Shibuya M, Imanaka T, Tamaru H, Masutani M, Ohyanagi M, Masuyama T. Impact of post-procedural intravascular ultrasound findings on long-term results following self-expanding nitinol stenting in superficial femoral artery lesions. Circ J 2013;77:1543-1550.
23. Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shin-tani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery. JACC Cardiovasc Interv 2014;7:792-798.
24. Neubauer B, Christensen NJ, Christensen T, Gundersen HJ, Jargensen J. Diabetic macroangiopathy. Medial calcifications, narrowing, rugosi-ties, stiffness, norepinephrine depletion and reduced blood flow capacity in the leg arteries. Acta Med Scand Suppl 1984;687:37-45.
25. Marso SP, Hiatt WR. Peripheral arterial disease in patients with dia-betes. J Am Coll Cardiol 2006;47:921-929.
26. Soga Y, Yokoi H, Kawasaki T, Nakashima H, Tsurugida M, Hikichi Y, Nobuyoshi M. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol 2009;53:48-53.
27. Iida O, Nanto S, Uematsu M, Morozumi T, Kitakaze M, Nagata S. Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions. J Vasc Surg 2008;48:144-149.
28. Kubota Y, Kichikawa K, Uchida H, Maeda M, Nishimine K, Makutani S, Sakaguchi S, Yoshioka T, Ohishi H, Kimura Y. Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries. Invest Radiol 1995;30:532-537.
29. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Snyder SA, O'Leary EE, Tepe G, Scheinert D, Zeller T, Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-Year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 2013;61:2417-2427.
30. Cassese S, Byrne RA, Ott I, Ndrepepa G, Nerad M, Kastrati A, Fusaro M. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopli-teal arterial disease: A meta-analysis of randomized trials. Circ Car-diovasc Interv 2012;5:582-589.
31. Unverdorben M, Kleber FX, Heuer H, Figulla HR, Vallbracht C, Leschke M, Cremers B, Hardt S, Buerke M, Ackermann H, Boxberger M, Degenhardt R, Scheller B. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: Are lesions clinically stable from 12 to 36 months? EuroIntervention 2013;9:620-628.
32. Siontis GC, Piccolo R, Praz F, Valgimigli M, Räber L, Mavridis D, Jüni P, Windecker S. Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: A network metaanalysis. JACC Cardiovasc Interv 2016;9:1324-1334.